Who to call at Specialised Therapeutics, and when
Fundz watches for the moments Specialised Therapeutics starts buying, and tells you who to reach.
- An alert the day Specialised Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Specialised Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Specialised Therapeutics. With Fundz connected, it knows.
Specialised Therapeutics Enhances Partnership with Incyte to Market Ruxolitinib Cream in Australia
Contract Type
partnership
Description
Specialised Therapeutics has announced an expansion of its partnership with Incyte to commercialize ruxolitinib cream in Australia. The agreement includes responsibilities for regulatory submissions, medical affairs, marketing, and distribution by ST, while Incyte will handle development and manufacturing.
Quick answer
Specialised Therapeutics Enhances Partnership with Incyte to Market Ruxolitinib Cream in Australia (September 20, 2026). Specialised Therapeutics is based in Thailand.
- What agreement did Specialised Therapeutics announce on September 20, 2026?
- Specialised Therapeutics has announced an expansion of its partnership with Incyte to commercialize ruxolitinib cream in Australia. The agreement includes responsibilities for regulatory submissions, medical affairs, marketing, and distribution by ST, while Incyte will handle development and manufacturing.
- What does Specialised Therapeutics do?
- Specialised Therapeutics (ST) is an independent pharmaceutical company committed to developing and providing innovative therapies for patients with rare diseases.
- Where is Specialised Therapeutics based?
- Specialised Therapeutics is based in Thailand.
- Which similar companies announced agreements around the same time?
- Alexion (October 29, 2026), YD Bio Limited (October 20, 2026), RxMP Therapeutics (October 20, 2026) and Georgiamune (October 25, 2026) also announced agreements within 45 days of Specialised Therapeutics.
Source: Fundz verified event record.
Other recent agreements in Medical and Therapeutics
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- Wolves Foundation and Alexion extend partnership to support Wolves Disability FC and Wolves Wishes for three more years. (October 29, 2026)
- YD Bio and EG BioMed Form Partnership with JoiiUp to Launch AI Cancer Risk Assessment for Corporate Wellness. (October 20, 2026)
- DARPA Awards Up to $10.7 Million Contract to RxMP Therapeutics for Development of RMP-402. (October 20, 2026)
- Menarini and Georgiamune Enter $1.1 Billion License Agreement for Cancer Immunotherapy GIM-621. (October 25, 2026)
- Rhode Island Life Science Hub and Cognito Therapeutics launch partnership for Alzheimer's research. (October 27, 2026)
- BioMarin Enters Exclusive License Agreement With GC Biopharma and Hanmi Pharm for HM15421/GC1134A to Treat Fabry Disease. (October 29, 2026)
Agreement Insights
What this usually meansSpecialised Therapeutics signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.